10-Q Filing

Niagen Bioscience, Inc. CIK: 1386570 Q2 2023

Filing Information

Form Type	10-Q
Accession Number	`0001628280-23-028551`
Period End Date	20230630
Filing Date	20230809
Fiscal Year	2023
Fiscal Period	Q2
XBRL Instance	cdcx-20230630_htm.xml

Filing Contents

This filing contains the following financial statements:

Balance Sheet 72 Income Statement 56 Cash Flow Statement 73 Stockholders Equity 29

Balance Sheet 72 line items

Line Item	Tag	Value	Unit	Period
Restricted cash	`RestrictedCash`	$152.00K	USD	Point-in-time
Restricted cash	`RestrictedCash`	$152.00K	USD	Point-in-time
Restricted cash	`RestrictedCash`	$152.00K	USD	Point-in-time
Restricted cash	`RestrictedCash`	$152.00K	USD	Point-in-time
Trade receivables, allowance	`AllowanceForDoubtfulAccountsReceivableCurrent`	$826.00K	USD	Point-in-time
Trade receivables, allowance	`AllowanceForDoubtfulAccountsReceivableCurrent`	$122.00K	USD	Point-in-time
Cash and cash equivalents, including restricted cash of $152 for both periods presented	`CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents`	$26.41M	USD	Point-in-time
Cash and cash equivalents, including restricted cash of $152 for both periods presented	`CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents`	$28.22M	USD	Point-in-time
Cash and cash equivalents, including restricted cash of $152 for both periods presented	`CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents`	$20.44M	USD	Point-in-time
Cash and cash equivalents, including restricted cash of $152 for both periods presented	`CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents`	$17.07M	USD	Point-in-time
Common stock, par value (in dollars per share)	`CommonStockParOrStatedValuePerShare`	$0.00	USD	Point-in-time
Common stock, par value (in dollars per share)	`CommonStockParOrStatedValuePerShare`	$0.00	USD	Point-in-time
Common stock authorized (in shares)	`CommonStockSharesAuthorized`	150.00M	shares	Point-in-time
Common stock authorized (in shares)	`CommonStockSharesAuthorized`	150.00M	shares	Point-in-time
Inventories	`InventoryNet`	$11.97M	USD	Point-in-time
Inventories	`InventoryNet`	$14.68M	USD	Point-in-time
Common stock issued (in shares)	`CommonStockSharesIssued`	74.86M	shares	Point-in-time
Common stock issued (in shares)	`CommonStockSharesIssued`	74.57M	shares	Point-in-time
Prepaid expenses and other assets	`PrepaidExpenseAndOtherAssets`	$2.97M	USD	Point-in-time
Prepaid expenses and other assets	`PrepaidExpenseAndOtherAssets`	$1.89M	USD	Point-in-time
Total current assets	`AssetsCurrent`	$46.57M	USD	Point-in-time
Common stock outstanding (in shares)	`CommonStockSharesOutstanding`	74.57M	shares	Point-in-time
Common stock outstanding (in shares)	`CommonStockSharesOutstanding`	74.86M	shares	Point-in-time
Total current assets	`AssetsCurrent`	$46.38M	USD	Point-in-time
Leasehold improvements and equipment, net	`PropertyPlantAndEquipmentAndFinanceLeaseRightOfUseAssetAfterAccumulatedDepreciationAndAmortization`	$2.80M	USD	Point-in-time
Leasehold improvements and equipment, net	`PropertyPlantAndEquipmentAndFinanceLeaseRightOfUseAssetAfterAccumulatedDepreciationAndAmortization`	$2.50M	USD	Point-in-time
Intangible assets, net	`IntangibleAssetsNetExcludingGoodwill`	$591.00K	USD	Point-in-time
Intangible assets, net	`IntangibleAssetsNetExcludingGoodwill`	$671.00K	USD	Point-in-time
Right-of-use assets, net	`OperatingLeaseRightOfUseAsset`	$3.18M	USD	Point-in-time
Right-of-use assets, net	`OperatingLeaseRightOfUseAsset`	$3.52M	USD	Point-in-time
Other long-term assets	`OtherAssetsNoncurrent`	$518.00K	USD	Point-in-time
Other long-term assets	`OtherAssetsNoncurrent`	$497.00K	USD	Point-in-time
Total assets	`Assets`	$54.06M	USD	Point-in-time
Total assets	`Assets`	$53.17M	USD	Point-in-time
Accounts payable	`AccountsPayableCurrent`	$10.03M	USD	Point-in-time
Accounts payable	`AccountsPayableCurrent`	$9.68M	USD	Point-in-time
Accrued expenses	`AccruedLiabilitiesCurrent`	$8.08M	USD	Point-in-time
Accrued expenses	`AccruedLiabilitiesCurrent`	$7.34M	USD	Point-in-time
Current maturities of operating lease obligations	`OperatingLeaseLiabilityCurrent`	$680.00K	USD	Point-in-time
Current maturities of operating lease obligations	`OperatingLeaseLiabilityCurrent`	$775.00K	USD	Point-in-time
Current maturities of finance lease obligations	`FinanceLeaseLiabilityCurrent`	$16.00K	USD	Point-in-time
Current maturities of finance lease obligations	`FinanceLeaseLiabilityCurrent`	$10.00K	USD	Point-in-time
Customer deposits	`DeferredIncomeCurrent`	$157.00K	USD	Point-in-time
Customer deposits	`DeferredIncomeCurrent`	$166.00K	USD	Point-in-time
Total current liabilities	`LiabilitiesCurrent`	$17.87M	USD	Point-in-time
Total current liabilities	`LiabilitiesCurrent`	$19.06M	USD	Point-in-time
Deferred revenue	`ContractWithCustomerLiabilityNoncurrent`	$3.81M	USD	Point-in-time
Deferred revenue	`ContractWithCustomerLiabilityNoncurrent`	$3.96M	USD	Point-in-time
Operating lease obligations, less current maturities	`OperatingLeaseLiabilityNoncurrent`	$3.14M	USD	Point-in-time
Operating lease obligations, less current maturities	`OperatingLeaseLiabilityNoncurrent`	$3.54M	USD	Point-in-time
Finance lease obligations, less current maturities	`FinanceLeaseLiabilityNoncurrent`	$17.00K	USD	Point-in-time
Finance lease obligations, less current maturities	`FinanceLeaseLiabilityNoncurrent`	$22.00K	USD	Point-in-time
Total liabilities	`Liabilities`	$26.02M	USD	Point-in-time
Total liabilities	`Liabilities`	$25.39M	USD	Point-in-time
Commitments and Contingencies (Note 10)	`CommitmentsAndContingencies`	-	USD	Point-in-time
Commitments and Contingencies (Note 10)	`CommitmentsAndContingencies`	-	USD	Point-in-time
Common stock, $0.001 par value; authorized 150,000 shares; 74,856 shares and 74,567 shares issued and outstanding at June 30, 2023 and December 31, 2022, respectively	`CommonStockValue`	$75.00K	USD	Point-in-time
Common stock, $0.001 par value; authorized 150,000 shares; 74,856 shares and 74,567 shares issued and outstanding at June 30, 2023 and December 31, 2022, respectively	`CommonStockValue`	$74.00K	USD	Point-in-time
Additional paid-in capital	`AdditionalPaidInCapital`	$214.09M	USD	Point-in-time
Additional paid-in capital	`AdditionalPaidInCapital`	$216.69M	USD	Point-in-time
Accumulated deficit	`RetainedEarningsAccumulatedDeficit`	$-185.49M	USD	Point-in-time
Accumulated deficit	`RetainedEarningsAccumulatedDeficit`	$-189.62M	USD	Point-in-time
Cumulative translation adjustments	`TranslationAdjustmentFunctionalToReportingCurrencyNetOfTax`	$-1.00K	USD	Point-in-time
Cumulative translation adjustments	`TranslationAdjustmentFunctionalToReportingCurrencyNetOfTax`	$-3.00K	USD	Point-in-time
Total stockholders' equity	`StockholdersEquity`	$25.88M	USD	Point-in-time
Total stockholders' equity	`StockholdersEquity`	$28.02M	USD	Point-in-time
Total stockholders' equity	`StockholdersEquity`	$27.15M	USD	Point-in-time
Total stockholders' equity	`StockholdersEquity`	$31.73M	USD	Point-in-time
Total stockholders' equity	`StockholdersEquity`	$20.78M	USD	Point-in-time
Total stockholders' equity	`StockholdersEquity`	$28.67M	USD	Point-in-time
Total liabilities and stockholders' equity	`LiabilitiesAndStockholdersEquity`	$54.06M	USD	Point-in-time
Total liabilities and stockholders' equity	`LiabilitiesAndStockholdersEquity`	$53.17M	USD	Point-in-time

Income Statement 56 line items

Line Item	Tag	Value	Unit	Period
Sales, net	`Revenues`	$33.99M	USD	2 Qtrs
Sales, net	`Revenues`	$16.73M	USD	1 Quarter
Sales, net	`Revenues`	$20.32M	USD	1 Quarter
Sales, net	`Revenues`	$42.88M	USD	2 Qtrs
Cost of sales	`CostOfRevenue`	$7.97M	USD	1 Quarter
Cost of sales	`CostOfRevenue`	$17.00M	USD	2 Qtrs
Cost of sales	`CostOfRevenue`	$13.42M	USD	2 Qtrs
Cost of sales	`CostOfRevenue`	$6.69M	USD	1 Quarter
Gross profit	`GrossProfit`	$20.57M	USD	2 Qtrs
Gross profit	`GrossProfit`	$10.04M	USD	1 Quarter
Gross profit	`GrossProfit`	$12.36M	USD	1 Quarter
Gross profit	`GrossProfit`	$25.87M	USD	2 Qtrs
Sales and marketing	`SellingAndMarketingExpense`	$13.88M	USD	2 Qtrs
Sales and marketing	`SellingAndMarketingExpense`	$8.02M	USD	1 Quarter
Sales and marketing	`SellingAndMarketingExpense`	$6.01M	USD	1 Quarter
Sales and marketing	`SellingAndMarketingExpense`	$16.26M	USD	2 Qtrs
Research and development	`ResearchAndDevelopmentExpense`	$2.56M	USD	2 Qtrs
Research and development	`ResearchAndDevelopmentExpense`	$1.25M	USD	1 Quarter
Research and development	`ResearchAndDevelopmentExpense`	$2.32M	USD	2 Qtrs
Research and development	`ResearchAndDevelopmentExpense`	$1.36M	USD	1 Quarter
General and administrative	`GeneralAndAdministrativeExpense`	$13.72M	USD	2 Qtrs
General and administrative	`GeneralAndAdministrativeExpense`	$7.16M	USD	1 Quarter
General and administrative	`GeneralAndAdministrativeExpense`	$16.11M	USD	2 Qtrs
General and administrative	`GeneralAndAdministrativeExpense`	$7.30M	USD	1 Quarter
Total operating expenses	`OperatingExpenses`	$30.16M	USD	2 Qtrs
Total operating expenses	`OperatingExpenses`	$14.67M	USD	1 Quarter
Total operating expenses	`OperatingExpenses`	$34.69M	USD	2 Qtrs
Total operating expenses	`OperatingExpenses`	$16.43M	USD	1 Quarter
Operating loss	`OperatingIncomeLoss`	$-4.28M	USD	2 Qtrs
Operating loss	`OperatingIncomeLoss`	$-14.12M	USD	2 Qtrs
Operating loss	`OperatingIncomeLoss`	$-6.39M	USD	1 Quarter
Operating loss	`OperatingIncomeLoss`	$-2.32M	USD	1 Quarter
Interest income (expense), net	`InterestIncomeExpenseNet`	$-18.00K	USD	2 Qtrs
Interest income (expense), net	`InterestIncomeExpenseNet`	$-10.00K	USD	1 Quarter
Interest income (expense), net	`InterestIncomeExpenseNet`	$191.00K	USD	2 Qtrs
Interest income (expense), net	`InterestIncomeExpenseNet`	$125.00K	USD	1 Quarter
Net loss	`NetIncomeLoss`	$-2.19M	USD	1 Quarter
Net loss	`NetIncomeLoss`	$-14.14M	USD	2 Qtrs
Net loss	`NetIncomeLoss`	$-4.09M	USD	2 Qtrs
Net loss	`NetIncomeLoss`	$-6.40M	USD	1 Quarter
Basic loss per common share attributable to ChromaDex Corporation (in dollars per share)	`EarningsPerShareBasic`	$-0.21	USD	2 Qtrs
Basic loss per common share attributable to ChromaDex Corporation (in dollars per share)	`EarningsPerShareBasic`	$-0.03	USD	1 Quarter
Basic loss per common share attributable to ChromaDex Corporation (in dollars per share)	`EarningsPerShareBasic`	$-0.09	USD	1 Quarter
Basic loss per common share attributable to ChromaDex Corporation (in dollars per share)	`EarningsPerShareBasic`	$-0.05	USD	2 Qtrs
Diluted loss per common share attributable to ChromaDex Corporation (in dollars per share)	`EarningsPerShareDiluted`	$-0.21	USD	2 Qtrs
Diluted loss per common share attributable to ChromaDex Corporation (in dollars per share)	`EarningsPerShareDiluted`	$-0.03	USD	1 Quarter
Diluted loss per common share attributable to ChromaDex Corporation (in dollars per share)	`EarningsPerShareDiluted`	$-0.05	USD	2 Qtrs
Diluted loss per common share attributable to ChromaDex Corporation (in dollars per share)	`EarningsPerShareDiluted`	$-0.09	USD	1 Quarter
Basic weighted average common shares outstanding (in shares)	`WeightedAverageNumberOfSharesOutstandingBasic`	68.34M	shares	1 Quarter
Basic weighted average common shares outstanding (in shares)	`WeightedAverageNumberOfSharesOutstandingBasic`	74.97M	shares	1 Quarter
Basic weighted average common shares outstanding (in shares)	`WeightedAverageNumberOfSharesOutstandingBasic`	68.33M	shares	2 Qtrs
Basic weighted average common shares outstanding (in shares)	`WeightedAverageNumberOfSharesOutstandingBasic`	74.88M	shares	2 Qtrs
Diluted weighted average common shares outstanding (in shares)	`WeightedAverageNumberOfDilutedSharesOutstanding`	74.97M	shares	1 Quarter
Diluted weighted average common shares outstanding (in shares)	`WeightedAverageNumberOfDilutedSharesOutstanding`	74.88M	shares	2 Qtrs
Diluted weighted average common shares outstanding (in shares)	`WeightedAverageNumberOfDilutedSharesOutstanding`	68.34M	shares	1 Quarter
Diluted weighted average common shares outstanding (in shares)	`WeightedAverageNumberOfDilutedSharesOutstanding`	68.33M	shares	2 Qtrs

Cash Flow Statement 73 line items

Line Item	Tag	Value	Unit	Period
Restricted cash	`RestrictedCash`	$152.00K	USD	Point-in-time
Restricted cash	`RestrictedCash`	$152.00K	USD	Point-in-time
Restricted cash	`RestrictedCash`	$152.00K	USD	Point-in-time
Restricted cash	`RestrictedCash`	$152.00K	USD	Point-in-time
Net loss	`NetIncomeLoss`	$-2.19M	USD	1 Quarter
Net loss	`NetIncomeLoss`	$-14.14M	USD	2 Qtrs
Net loss	`NetIncomeLoss`	$-4.09M	USD	2 Qtrs
Net loss	`NetIncomeLoss`	$-6.40M	USD	1 Quarter
Depreciation of leasehold improvements and equipment	`Depreciation`	$460.00K	USD	2 Qtrs
Depreciation of leasehold improvements and equipment	`Depreciation`	$413.00K	USD	2 Qtrs
Amortization of intangibles	`AmortizationOfIntangibleAssets`	$80.00K	USD	2 Qtrs
Amortization of intangibles	`AmortizationOfIntangibleAssets`	$99.00K	USD	2 Qtrs
Amortization of right of use assets	`OperatingLeaseRightOfUseAssetAmortizationExpense`	$344.00K	USD	2 Qtrs
Amortization of right of use assets	`OperatingLeaseRightOfUseAssetAmortizationExpense`	$468.00K	USD	2 Qtrs
Share-based compensation expense	`ShareBasedCompensation`	$1.32M	USD	1 Quarter
Share-based compensation expense	`ShareBasedCompensation`	$1.30M	USD	1 Quarter
Share-based compensation expense	`ShareBasedCompensation`	$2.60M	USD	2 Qtrs
Share-based compensation expense	`ShareBasedCompensation`	$3.18M	USD	2 Qtrs
Loss on disposal of leasehold improvements and equipment	`GainLossOnSaleOfPropertyPlantEquipment`	$-22.00K	USD	2 Qtrs
Loss on disposal of leasehold improvements and equipment	`GainLossOnSaleOfPropertyPlantEquipment`	$5.00K	USD	2 Qtrs
Provision for doubtful trade receivables	`ProvisionForDoubtfulAccounts`	$400.00K	USD	1 Quarter
Provision for doubtful trade receivables	`ProvisionForDoubtfulAccounts`	$751.00K	USD	2 Qtrs
Provision for doubtful trade receivables	`ProvisionForDoubtfulAccounts`	$5.00K	USD	2 Qtrs
Non-cash financing costs	`OtherNoncashIncomeExpense`	$-34.00K	USD	2 Qtrs
Non-cash financing costs	`OtherNoncashIncomeExpense`	$-42.00K	USD	2 Qtrs
Trade receivables	`IncreaseDecreaseInOtherReceivables`	$-976.00K	USD	2 Qtrs
Trade receivables	`IncreaseDecreaseInOtherReceivables`	$-1.58M	USD	2 Qtrs
Inventories	`IncreaseDecreaseInInventories`	$-2.70M	USD	2 Qtrs
Inventories	`IncreaseDecreaseInInventories`	$2.15M	USD	2 Qtrs
Implementation costs for cloud computing arrangement	`ImplementationCostsForCloudComputingArrangement`	$204.00K	USD	2 Qtrs
Implementation costs for cloud computing arrangement	`ImplementationCostsForCloudComputingArrangement`	$60.00K	USD	2 Qtrs
Prepaid expenses and other assets	`IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets`	$-529.00K	USD	2 Qtrs
Prepaid expenses and other assets	`IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets`	$-1.02M	USD	2 Qtrs
Accounts payable	`IncreaseDecreaseInAccountsPayable`	$352.00K	USD	2 Qtrs
Accounts payable	`IncreaseDecreaseInAccountsPayable`	$-226.00K	USD	2 Qtrs
Accrued expenses	`IncreaseDecreaseInAccruedLiabilities`	$215.00K	USD	2 Qtrs
Accrued expenses	`IncreaseDecreaseInAccruedLiabilities`	$742.00K	USD	2 Qtrs
Deferred revenue	`IncreaseDecreaseInContractWithCustomerLiability`	$-149.00K	USD	2 Qtrs
Deferred revenue	`IncreaseDecreaseInContractWithCustomerLiability`	$-118.00K	USD	2 Qtrs
Customer deposits and other	`IncreaseDecreaseInDeferredRevenue`	$16.00K	USD	2 Qtrs
Customer deposits and other	`IncreaseDecreaseInDeferredRevenue`	$11.00K	USD	2 Qtrs
Operating lease liabilities	`IncreaseDecreaseInOperatingLeaseLiability`	$-307.00K	USD	2 Qtrs
Operating lease liabilities	`IncreaseDecreaseInOperatingLeaseLiability`	$-154.00K	USD	2 Qtrs
Net cash provided by (used in) operating activities	`NetCashProvidedByUsedInOperatingActivities`	$6.07M	USD	2 Qtrs
Net cash provided by (used in) operating activities	`NetCashProvidedByUsedInOperatingActivities`	$-11.03M	USD	2 Qtrs
Purchases of leasehold improvements and equipment	`PurchasesOfLeaseholdImprovementsAndEquipment`	$101.00K	USD	2 Qtrs
Purchases of leasehold improvements and equipment	`PurchasesOfLeaseholdImprovementsAndEquipment`	$110.00K	USD	2 Qtrs
Proceeds from the sale of leasehold improvements and equipment, net	`ProceedsFromTheSaleOfLeaseholdImprovementsAndEquipmentNet`	-	USD	2 Qtrs
Proceeds from the sale of leasehold improvements and equipment, net	`ProceedsFromTheSaleOfLeaseholdImprovementsAndEquipmentNet`	$5.00K	USD	2 Qtrs
Net cash used in investing activities	`NetCashProvidedByUsedInInvestingActivities`	$-96.00K	USD	2 Qtrs
Net cash used in investing activities	`NetCashProvidedByUsedInInvestingActivities`	$-110.00K	USD	2 Qtrs
Principal payments on finance leases	`FinanceLeasePrincipalPayments`	$11.00K	USD	2 Qtrs
Principal payments on finance leases	`FinanceLeasePrincipalPayments`	$7.00K	USD	2 Qtrs
Net cash used in financing activities	`NetCashProvidedByUsedInFinancingActivities`	$-11.00K	USD	2 Qtrs
Net cash used in financing activities	`NetCashProvidedByUsedInFinancingActivities`	$-7.00K	USD	2 Qtrs
Net increase (decrease) in cash and cash equivalents	`CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect`	$-11.15M	USD	2 Qtrs
Net increase (decrease) in cash and cash equivalents	`CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect`	$5.96M	USD	2 Qtrs
Cash and cash equivalents, including restricted cash of $152 for both periods - beginning of period	`CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents`	$26.41M	USD	Point-in-time
Cash and cash equivalents, including restricted cash of $152 for both periods - beginning of period	`CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents`	$28.22M	USD	Point-in-time
Cash and cash equivalents, including restricted cash of $152 for both periods - beginning of period	`CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents`	$20.44M	USD	Point-in-time
Cash and cash equivalents, including restricted cash of $152 for both periods - beginning of period	`CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents`	$17.07M	USD	Point-in-time
Cash and cash equivalents, including restricted cash of $152 for both periods - end of period	`CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents`	$26.41M	USD	Point-in-time
Cash and cash equivalents, including restricted cash of $152 for both periods - end of period	`CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents`	$28.22M	USD	Point-in-time
Cash and cash equivalents, including restricted cash of $152 for both periods - end of period	`CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents`	$20.44M	USD	Point-in-time
Cash and cash equivalents, including restricted cash of $152 for both periods - end of period	`CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents`	$17.07M	USD	Point-in-time
Cash payments for principal on operating lease liabilities	`OperatingLeasePayments`	$204.00K	USD	2 Qtrs
Cash payments for principal on operating lease liabilities	`OperatingLeasePayments`	$342.00K	USD	2 Qtrs
Stockholders' equity attributable to parent	`StockholdersEquity`	$25.88M	USD	Point-in-time
Stockholders' equity attributable to parent	`StockholdersEquity`	$28.02M	USD	Point-in-time
Stockholders' equity attributable to parent	`StockholdersEquity`	$27.15M	USD	Point-in-time
Stockholders' equity attributable to parent	`StockholdersEquity`	$31.73M	USD	Point-in-time
Stockholders' equity attributable to parent	`StockholdersEquity`	$20.78M	USD	Point-in-time
Stockholders' equity attributable to parent	`StockholdersEquity`	$28.67M	USD	Point-in-time

Stockholders Equity 29 line items

Line Item	Tag	Value	Unit	Period
Beginning balance	`StockholdersEquity`	$25.88M	USD	Point-in-time
Beginning balance	`StockholdersEquity`	$28.02M	USD	Point-in-time
Beginning balance	`StockholdersEquity`	$27.15M	USD	Point-in-time
Beginning balance	`StockholdersEquity`	$31.73M	USD	Point-in-time
Beginning balance	`StockholdersEquity`	$20.78M	USD	Point-in-time
Beginning balance	`StockholdersEquity`	$28.67M	USD	Point-in-time
Issuance of restricted stock (in shares)	`StockIssuedDuringPeriodSharesRestrictedStockAwardNetOfForfeitures`	29,000.00	shares	2 Qtrs
Issuance of restricted stock	`StockIssuedDuringPeriodValueRestrictedStockAwardNetOfForfeitures`	-	USD	2 Qtrs
Issuance of restricted stock	`StockIssuedDuringPeriodValueRestrictedStockAwardNetOfForfeitures`	-	USD	1 Quarter
Issuance of restricted stock	`StockIssuedDuringPeriodValueRestrictedStockAwardNetOfForfeitures`	$1.00K	USD	1 Quarter
Issuance of restricted stock	`StockIssuedDuringPeriodValueRestrictedStockAwardNetOfForfeitures`	$1.00K	USD	2 Qtrs
Share-based compensation	`StockIssuedDuringPeriodValueShareBasedCompensation`	$3.18M	USD	2 Qtrs
Share-based compensation	`StockIssuedDuringPeriodValueShareBasedCompensation`	$1.30M	USD	1 Quarter
Share-based compensation	`StockIssuedDuringPeriodValueShareBasedCompensation`	$1.32M	USD	1 Quarter
Share-based compensation	`StockIssuedDuringPeriodValueShareBasedCompensation`	$2.60M	USD	2 Qtrs
Translation adjustment	`OtherComprehensiveIncomeForeignCurrencyTransactionAndTranslationAdjustmentNetOfTaxPortionAttributableToParent`	$2.00K	USD	1 Quarter
Translation adjustment	`OtherComprehensiveIncomeForeignCurrencyTransactionAndTranslationAdjustmentNetOfTaxPortionAttributableToParent`	$-1.00K	USD	1 Quarter
Translation adjustment	`OtherComprehensiveIncomeForeignCurrencyTransactionAndTranslationAdjustmentNetOfTaxPortionAttributableToParent`	$2.00K	USD	2 Qtrs
Translation adjustment	`OtherComprehensiveIncomeForeignCurrencyTransactionAndTranslationAdjustmentNetOfTaxPortionAttributableToParent`	$4.00K	USD	2 Qtrs
Net loss	`NetIncomeLoss`	$-2.19M	USD	1 Quarter
Net loss	`NetIncomeLoss`	$-14.14M	USD	2 Qtrs
Net loss	`NetIncomeLoss`	$-4.09M	USD	2 Qtrs
Net loss	`NetIncomeLoss`	$-6.40M	USD	1 Quarter
Ending balance	`StockholdersEquity`	$25.88M	USD	Point-in-time
Ending balance	`StockholdersEquity`	$28.02M	USD	Point-in-time
Ending balance	`StockholdersEquity`	$27.15M	USD	Point-in-time
Ending balance	`StockholdersEquity`	$31.73M	USD	Point-in-time
Ending balance	`StockholdersEquity`	$20.78M	USD	Point-in-time
Ending balance	`StockholdersEquity`	$28.67M	USD	Point-in-time

Data is extracted from SEC EDGAR XBRL filings. Values shown are as reported in the filing.